This invention relates to a closure for a syringe or other medical container having tamper evident capabilities and including a tip cap removably retained within the interior of an outer cover without the use of frangible structure interconnecting components of the closure. An outward flexure of a portion of the closure at least partially defines a snap-action disconnection of said tip cap from within an interior of the cover.
In numerous medical care facilities, it is common practice to administer various medications to a patient either orally or by injection. As a result, a number of syringes, IV bags, medication carrying containers, etc. may be pre-loaded within or supplied to the medical care facility and subsequently stored at different locations stations throughout the facility. At large medical facilities, preloaded syringes or other administering containers may be delivered to multiple nurses' stations. Because of the remote location of many nurse's stations, a pre-loaded syringe is very often given to other personnel for delivery or subsequent dosing of the patient by a duly qualified nurse or other medically trained person.
Also, in the case of a very expensive drug or an addictive type drug such as, but not limited to, morphine, there is a danger that the pre-loaded container will be tampered with at some point, by a person seeking to improperly gain unauthorized access to the drug. This possibility can present real danger when unauthorized access to the contents of the preloaded syringe, IV bag or other container is accomplished. One possible outcome of such a situation includes the inappropriate substitution of some other, unauthorized material in the syringe, IV container, etc. By way of example only, if saline solution were substituted for a dose of morphine, this could have extremely serious consequences. Thus, there is a problem of determining if a sealed, preloaded medication container has, or has not, been exposed to contamination or might otherwise have been compromised by it being tampered with. This and related types of problems have been described in U.S. Pat. No. 4,667,837 and in other patents, such as U.S. Pat. No. 5,328,474 granted previously to one or more of the named inventors herein and/or owned by their Assignee.
However, certain problems remain in the relevant field of art, despite the introduction of products represented in the above noted patents. Such problems are related to the manufacturing thereof in a manner which is relatively easy and inexpensive, as well as some problems involved with the assembly and placement of a protective, tamper evident structure onto a drug loaded container. Also, additional problems relate to the maintenance of sterility during storage at the manufacturing facility and during transport to and throughout the various medical facilities where they are used.
Further, known or conventional tamper evident tops typically rely on frangible and/or breakaway features. However, such frangible structures can be prone to breaking prematurely, even under normal shipping and handling conditions. If the closure breaks “accidentally” during manufacturing, transit or handling, the cost is relatively low in that it is limited to the disposal of the closure itself. However, if the closure breaks after being installed on a pre-filled syringe or other medical container, the cost may be considerably higher considering that the pre-filled syringe, etc. must also be disposed of.
In addition, use of medical closures incorporating breakaway components can result in the loose pieces being inadvertently discarded from the closure. This is particularly important in certain medical procedures, including surgery, especially if any such loose pieces were to enter the body of a patient, which could possibly result in serious damage to the patient. Moreover, structures of medical closures that rely on frangible features which may separate or “break” into a plurality of pieces during use have sometimes addressed the resulting problem by attempts to capture the broken/loose pieces in some manner.
Therefore, there is a need in the medical field and related areas of commerce for a medical closure, which may have tamper evident capabilities and which eliminates the use of frangible components or features substantially, if not completely. Moreover, if any such improved medical closure assembly were developed, it would preferably also offer a cost-effective solution for a Tamper Evident Closure or Cap (TEC) that meets all of the common/standard user needs including, but not necessarily limited to, reliability, simplicity of use, minimization or elimination of loose parts, and biocompatibility. Further, if any such improved medical closure were developed it would ideally also be structured to include or offer a snap fit type of construction.
Accordingly, the present invention seeks to address such problems and others associated with the handling of medical tamper evident closures structured for use with medication administering or storage containers during their manufacture, assembly, and administration.
As such and as illustrated in the drawings, the present invention is directed to a closure for a medical container having tamper evident capabilities which provide a clear indication that access to a syringe or other medical container, to which the closure is attached, has been attempted or accomplished. Moreover, at least some of the disadvantages and problems of the type set forth above and otherwise commonly associated with known or conventional tamper evident caps (TEC) has been overcome through the elimination of frangible or breakaway connections, components, etc.
Accordingly, the one or more preferred embodiments of the present invention include a tamper evident closure including an exterior cover which may be in the form of a sleeve-like structure having an at least partially hollow interior. In addition, the cover includes an access opening formed at one end thereof and an oppositely disposed closed-end. Further, the at least partially hollow interior of the cover is sufficiently dimensioned and configured to at least partially enclose a tip cap. The tip cap is removably retained within the interior of the cover and may be any one of a different category of structures, such as those commonly referred to in the medical industry as Lure, enteral, oral, neuraxial, etc.
As indicated herein, the various embodiments of the closure assembly of the present invention are structured to eliminate the utilization of frangible and/or breakaway type of components. Therefore, each of the one or more embodiments of the closure includes a first snap structure disposed within the cover and a second snap structure disposed on and movable with the removably retained tip cap. As such, the first and second snap structures are cooperatively disposed and configured to removably restrict exiting or removal of the tip cap from within the cover, such as through the access opening. However, as will be apparent securement of the tip cap to an appropriately structured or configured medical container, such as a syringe, will facilitate easy and effective removal of the tip cap from the cover, as intended. The first and second snap structures are disposed in movable engagement with one another, concurrent to the exiting or removal of the tip cap through the access opening.
Accordingly, at least one preferred embodiment of the tamper evident closure (TEC) of the present invention includes each of the first and second snap structures having an angled segment disposed thereon. The angled segments of each of the first and second snap structures are disposed in sliding engagement with one another, concurrent to the exiting or removal of the tip cap, through the access opening, as set forth above. In addition, removal of the tip cap from the cover is further facilitated by the cover being dimensioned and configured to define an “outward flexure” thereof concurrent to the first and second snap structures and more specifically the respective angled segments, being disposed in movable, sliding engagement with one another. In addition, the outward flexure of the cover occurring concurrent to the sliding engagement of the angled segments defines a “snap-action” disconnection of the tip cap from the cover as the first and second snap structures disengage from one another and further as the tip cap passes outwardly from the interior of the cover through the aforementioned access opening.
As indicated, the one or more embodiments of the closure of the present invention include tamper evident capabilities. Therefore, in at least one embodiment each of the first and second snap structures, in addition to the aforementioned angled segments, also include a stop segment. Each stop segment is formed on or connected to and movable with corresponding ones of the first and second snap structures and are disposable in abutting relation to one another upon an attempted reinsertion of the tip cap back into the interior of the cover. Such abutting engagement between the stop segments of the first and second snap structure prevent a complete reinsertion of the tip cap into the interior of the cover, thereby preventing disposition of the tip cap back into its original, operative, removably retained position. As a result, failure to reinsert the tip cap into the interior of the cover in its original, operative position will provide a clear indication that the tip cap and cover have been previously separated in an authorized or unauthorized (tampering) use of the closure.
As will be explained in greater detail hereinafter, the angled segments of the first and second snap structures may preferably be disposed at a substantially 120° angle relative respectively to the inner surface of the cover and the outer surface of the tip cap. Also, the stop segments of each of the first and second snap structures are respectfully disposed in substantially perpendicular relation respectively relative to the inner surface of the cover and the outer surface of the tip cap.
Yet additional structural and operative features of at least one embodiment of the TEC of the present invention include the first snap structure integrally formed or fixedly connected to an inner surface of the cover. In cooperation therewith, the second snap structure is integrally formed on and/or fixedly connected to the outer surface of the tip cap. Further, the disposition of the first and second snap structures, respectively on the inner surface of the cover and the outer surface of the tip cap is such as to facilitate their engagement, via the aforementioned angled segments, in a manner which will removably restrict exiting of the tip cap from the interior of the cover through the access opening. Similarly, the disposition and structuring of the first and second snap segments will prevent complete or total reinsertion of the tip cap into the interior of the cover, via the aforementioned stop segments, into the original, operative position of the tip cap, prior to its removal when connected to an appropriately configured syringe or other medical container/device. In order to assure intended engagement between the angled segments as well as the stop segments on the first and second snap connectors, at least one but preferably both of the first and second snap connectors have a continuous and/or annular configuration, as well as the angled segments and stop segments respectively formed thereon.
In at least one additional preferred embodiment, the TEC includes the first snap connector disposed within the interior of the cover concurrent to the second snap connector disposed on an exterior surface of the tip cap. However, this at least one additional embodiment comprises the inclusion of an indicator member having an annular or ring-like configuration. Further, the first snap structure is formed on an interior surface of the indicator member or indicator ring rather than on the interior surface of the cover. Therefore, the removable retention and/or exit restricting, retaining relation of the tip cap within the interior of the cover is accomplished by virtue of engagement of the first and second snap structures.
Additional structural and operative features of this additional preferred embodiment of the TEC includes the aforementioned exit retaining relation of the tip cap occurring concurrently to the indicator member or ring being initially maintained in a “trapped” orientation between the tip cap and an interior surface of the cover. Further, the indicator ring is disposed and dimension to be disposed in surrounding relation to the tip cap in order to facilitate initial engagement of the first and second snap connectors with one another, prior to the removal of the tip cap from the interior of the cover. As such, the outer diameter of the indicator ring is greater than the inner diameter of the access opening and/or a corresponding diametrical dimension of an interior surface portion or “shelf” of the cover. As a result, upon detachment of the tip cap from the indicator ring, concurrent to its removal through the access opening, the indicator ring will be prevented from moving with the tip cap from within the interior of the cover.
Therefore, due to the interaction of the first and second snap structures on the indicator ring and the tip cap respectively, as well as the larger diametrical dimension of the indicator ring, the indicator ring will be “captured” within a remainder or chamber portion of the interior of the cover. In more specific terms, the indicator ring will move or be forced, at least partially due to the influence of gravity thereon, from the “trapped” orientation into the “captured” orientation, concurrent and/or subsequent to a snap-action detachment of the tip cap from the indicator ring.
Yet additional features of this additional one or more preferred embodiments of the TEC of the present invention include each of the first and second snap structures having an angled segment integrally or fixedly formed thereon, so as to move therewith. The angled segments of the first and second snap structures of this additional embodiment can be structurally and/or operationally equivalent or at least similar to those described with the above-noted other embodiment of the TEC. Therefore, the angled segments of the first and second snap structures respectively associated with the indicator ring and the tip cap are disposed in movable, sliding engagement with one another, concurrent to the exiting or removal of the tip cap through the access opening, such as when the tip cap is connected to a syringe or other appropriately configured medical container or device. Further, the indicator member is dimensioned and structured to define an outward flexure thereof, concurrent to the sliding engagement of said angled segments. This at least minimal outward flexure will facilitate the aforementioned movable sliding engagement and disconnection of the angled segments of the first and second snap structures. In turn, at least a minimal outward flexure of the indicator ring will at least partially define a snap-action disconnection of said first and second snap structures as well as a snap-action disconnection of the tip cap from said indicator member, when the indicator member is in the aforementioned trapped orientation.
However, one distinguishing structural feature in the one or more additional embodiments of the TEC of the present invention comprises an absence of the aforementioned stop segments on the first and second snap structures. As a result, the tip cap may be capable of being reinserted into the interior of the cover. However, when the indicator ring is disposed in the aforementioned “captured” orientation it will generally be disposed in supported relation on the interior surface of the bottom or closed-end of the cover. In turn, the second snap structure disposed on the exterior surface of the tip cap will be sufficiently spaced from the indicator ring, even when the tip cap is fully re-inserted on the interior of the cover to prevent reattachment or engagement of the first and second snap structures. Therefore, the aforementioned tamper evident capabilities of this additional one or more embodiments of the TEC of the present invention will be at least partially defined by a failure to retain the tip cap within the cover and/or establish a reconnection or attachment between the first and second snap structures of the indicator ring and the tip cap.
These and other objects, features and advantages of the present invention will become clearer when the drawings as well as the detailed description are taken into consideration.
For a fuller understanding of the nature of the present invention, reference should be had to the following detailed description taken in connection with the accompanying drawings in which:
Like reference numerals refer to like parts throughout the several views of the drawings.
The invention will now be described more fully hereinafter with reference to the accompanying drawings in which illustrative embodiments of the invention are shown. This invention may, however, be embodied in many different forms and should not be construed as limited to the embodiments set forth herein; rather, these embodiments are provided so that this disclosure will be thorough and complete, and will fully convey the scope of the invention to those skilled in the art.
With initial reference to
For reasons which will be more evident based on the included description of the one or more embodiments of the closure 10 of the present invention, insertion of the tip cap 20 into the interior 14 of the cover 12 may be more efficiently accomplished by inserting it through one end of the cover, oppositely disposed to the access opening 16 and thereafter securing the closed end to the one end, such as by sonic welding or the like.
As emphasized, the one or more preferred embodiments of the closure 10 of the present invention are structured to eliminate the utilization of frangible and/or breakaway type of components or connections. Therefore, each of the one or more embodiments of the closure 10, 10′ (see
In more specific terms, at least one preferred embodiment of the tamper evident closure (TEC), as represented in
Therefore, the cover 12 and/or at least a portion thereof is dimensioned and/or structured to define an “outward flexure” thereof concurrent to the first and second snap structures 22 and 24 and more specifically the respective angled segments 26 and 28, movably and slidingly engaging with one another. As indicated, such movable, sliding engagement between the confronting surfaces of the respective angled segments 26 and 28 occurs concurrent to the tip cap 20, once attached to a syringe, being forced outwardly from the interior 14 of the cover 12, through the access opening 16. In addition, the outward flexure of the cover 12 occurring concurrent to the sliding engagement of the angled segments defines a “snap-action” disconnection of the tip cap 20 from the cover 12 as the first and second snap structures 22 and 24 disengage from one another and further as the tip cap 20 passes outwardly from the interior 14 of the cover through the aforementioned access opening 16.
As indicated, the one or more embodiments of the closure 10, 10′ of the present invention include tamper evident capabilities. Therefore, in at least one embodiment as represented in FIGS. 1-3A, each of the first and second snap structures 22 and 24, in addition to the aforementioned angled segments 26 and 28, also include a stop segment 30 and 32. Each stop segment 30 and 32 is formed on or connected to and movable with corresponding ones of the first and second snap structures 22 and 24 and are disposable in abutting relation to one another, as represented in FIGS. and 3A, upon an attempted reinsertion of the tip cap 20 back into the interior 14 of the cover. Such abutting engagement between the stop segments 30 and 32 of the first and second snap structure 22 and 24 prevent a complete reinsertion of the tip cap 20 into the interior 14 of the cover 12, thereby preventing disposition and retention of the tip cap 20 back into its original, operative, removably retained position, such as represented in
As will be explained in greater detail hereinafter, the angled segments 26 and 28 of the first and second snap structures 22 and 24 may preferably be disposed at, but not limited to, a substantially 120° angle relative respectively to the inner surface of the cover 12 and the outer surface of the tip cap 20. Also, the stop segments 30 and 32 of each of the first and second snap structures 22 and 24 are respectfully disposed in substantially perpendicular relation to the inner surface of the cover 12 and the outer surface of the tip cap 20, respectively. However, it is emphasized that the stop segments 30 and 32 may be located at angular orientations other than perpendicular, where in such other angular orientations would be sufficient to prevent passage and retention of the tip cap 20 back into the interior 14 of the cover 12.
Yet additional structural and operative features of one or more embodiments of the TEC of the present invention, as represented in
In at least one additional embodiment as represented in
Additional structural and operative features of this additional embodiment of the closure 10′ includes the aforementioned exit retaining relation of the tip cap 20 occurring concurrently to the indicator member or ring 40 being initially maintained in a “trapped” orientation between the tip cap 20 and an interior surface of the cover 12″, as represented in
More specifically, the interior 14 of the cover 12, as represented in
Therefore, due to the interaction of the first and second snap structures 22′ in 24 on the indicator ring 40 and the tip cap 20 respectively, as well as the larger diametrical dimension of the indicator ring 40, the indicator ring 40 will be “captured” within chamber 46 of the interior of the cover 12. In more specific terms, the indicator ring 40 will move or be forced, at least partially due to the influence of gravity thereon, from the “trapped” orientation of
Yet additional features of this additional one or more preferred embodiments of the closure 10′ include each of the first and second snap structures 22′ in 24 having an angled segment 26 and integrally or fixedly formed thereon, so as to move therewith. The angled segments 26 and 28 of the first and second snap structures 22′ in 24 of this additional embodiment can be structurally and/or operationally equivalent or at least similar to those described with the above-noted embodiment of the closure 10, as represented in
However, one distinguishing structural feature of the at least one embodiment represented in
Since many modifications, variations and changes in detail can be made to the described preferred embodiment of the invention, it is intended that all matters in the foregoing description and shown in the accompanying drawings be interpreted as illustrative and not in a limiting sense. Thus, the scope of the invention should be determined by the appended claims and their legal equivalents.
The present application is based on and a claim of priority is made under 35 U.S.C. Section 119(e) to a provisional patent application that is currently pending in the U.S. Patent and Trademark Office, namely, that having Ser. No. 63/125,156 and a filing date of Dec. 14, 2020, and which is incorporated herein by reference.
Number | Name | Date | Kind |
---|---|---|---|
722943 | Chappell | Mar 1903 | A |
732662 | Smith | Jun 1903 | A |
1678991 | Marschalek | Jul 1928 | A |
1970631 | Sherman | Aug 1934 | A |
2477598 | Hain | Aug 1949 | A |
2739590 | Yochem | Mar 1956 | A |
2823674 | Yochem | Feb 1958 | A |
2834346 | Adams | May 1958 | A |
2875761 | Helmer et al. | Mar 1959 | A |
2888015 | Hunt | May 1959 | A |
2952255 | Hein, Jr. | Sep 1960 | A |
3122280 | Goda | Feb 1964 | A |
3245567 | Knight | Apr 1966 | A |
3323798 | Miller | Jun 1967 | A |
3364890 | Andersen | Jan 1968 | A |
3368673 | Johnson | Feb 1968 | A |
3489268 | Meierhoefer | Jan 1970 | A |
3574306 | Alden | Apr 1971 | A |
3598120 | Mass | Aug 1971 | A |
3610241 | LeMarie | Oct 1971 | A |
3674181 | Marks et al. | Jul 1972 | A |
3700215 | Hardman et al. | Oct 1972 | A |
3706307 | Hasson | Dec 1972 | A |
3712749 | Roberts | Jan 1973 | A |
3726445 | Ostrowsky et al. | Apr 1973 | A |
3747751 | Miller et al. | Jul 1973 | A |
3850329 | Robinson | Nov 1974 | A |
3872867 | Killinger | Mar 1975 | A |
3904033 | Haerr | Sep 1975 | A |
3905375 | Toyama | Sep 1975 | A |
3937211 | Merten | Feb 1976 | A |
3987930 | Fuson | Oct 1976 | A |
4005739 | Winchell | Feb 1977 | A |
4043334 | Brown et al. | Aug 1977 | A |
4046145 | Choksi et al. | Sep 1977 | A |
4068696 | Winchell | Jan 1978 | A |
4106621 | Sorenson | Aug 1978 | A |
4216585 | Hatter | Aug 1980 | A |
4216872 | Bean | Aug 1980 | A |
4244366 | Raines | Jan 1981 | A |
4252122 | Halvorsen | Feb 1981 | A |
4271972 | Thor | Jun 1981 | A |
4286591 | Raines | Sep 1981 | A |
4286640 | Knox et al. | Sep 1981 | A |
4313539 | Raines | Feb 1982 | A |
4369781 | Gilson et al. | Jan 1983 | A |
4420085 | Wilson et al. | Dec 1983 | A |
4430077 | Mittleman et al. | Feb 1984 | A |
4457445 | Hanks et al. | Jul 1984 | A |
4482071 | Ishiwatari | Nov 1984 | A |
D277783 | Beck | Feb 1985 | S |
4521237 | Logothetis | Jun 1985 | A |
4530697 | Kuhlemann et al. | Jul 1985 | A |
4571242 | Klien et al. | Feb 1986 | A |
4589171 | McGill | May 1986 | A |
4664259 | Landis | May 1987 | A |
4667837 | Vitello et al. | May 1987 | A |
4676530 | Nordgren et al. | Jun 1987 | A |
4693707 | Dye | Sep 1987 | A |
4726483 | Drozd | Feb 1988 | A |
4735617 | Nelson et al. | Apr 1988 | A |
4742910 | Staebler | May 1988 | A |
4743229 | Chu | May 1988 | A |
4743231 | Kay et al. | May 1988 | A |
4760847 | Vaillancourt | Aug 1988 | A |
4813564 | Cooper et al. | Mar 1989 | A |
4832695 | Rosenberg et al. | May 1989 | A |
4834706 | Beck et al. | May 1989 | A |
4842592 | Caggiani et al. | Jun 1989 | A |
4844906 | Hermelin et al. | Jul 1989 | A |
4906231 | Young | Mar 1990 | A |
4919285 | Roof et al. | Apr 1990 | A |
4936445 | Grabenkort | Jun 1990 | A |
5009323 | Montgomery et al. | Apr 1991 | A |
5024323 | Bolton | Jun 1991 | A |
5049129 | Zdeb et al. | Sep 1991 | A |
D323392 | Bryne | Jan 1992 | S |
5078696 | Nedbaluk | Jan 1992 | A |
5085332 | Gettig et al. | Feb 1992 | A |
5090564 | Chimienti | Feb 1992 | A |
5133454 | Hammer | Jul 1992 | A |
5135496 | Vetter et al. | Aug 1992 | A |
5163922 | McElveen, Jr. et al. | Nov 1992 | A |
5165560 | Ennis, III et al. | Nov 1992 | A |
5230429 | Etheredge, III | Jul 1993 | A |
5267983 | Oilschlager et al. | Dec 1993 | A |
5292308 | Ryan | Mar 1994 | A |
5293993 | Yates, Jr. et al. | Mar 1994 | A |
5295599 | Smith | Mar 1994 | A |
5312367 | Nathan | May 1994 | A |
5312368 | Haynes | May 1994 | A |
5328466 | Denmark | Jul 1994 | A |
5328474 | Raines | Jul 1994 | A |
5356380 | Hoekwater et al. | Oct 1994 | A |
5370226 | Gollobin et al. | Dec 1994 | A |
5380295 | Vacca | Jan 1995 | A |
5402887 | Shillington | Apr 1995 | A |
5405339 | Kohnen et al. | Apr 1995 | A |
5456668 | Ogle, II | Oct 1995 | A |
5458580 | Hajishoreh | Oct 1995 | A |
5468224 | Souryal | Nov 1995 | A |
5474178 | DiViesti et al. | Dec 1995 | A |
5505705 | Galpin et al. | Apr 1996 | A |
5531695 | Swisher | Jul 1996 | A |
5540324 | Knapp | Jul 1996 | A |
5540666 | Barta et al. | Jul 1996 | A |
5549571 | Sak | Aug 1996 | A |
5558648 | Shields | Sep 1996 | A |
5584817 | van den Haak | Dec 1996 | A |
5588239 | Anderson | Dec 1996 | A |
5617954 | Kato et al. | Apr 1997 | A |
5624402 | Imbert | Apr 1997 | A |
5662233 | Reid | Sep 1997 | A |
5674209 | Yarger | Oct 1997 | A |
5695470 | Roussigne et al. | Dec 1997 | A |
5699913 | Richardson | Dec 1997 | A |
5700247 | Grimard et al. | Dec 1997 | A |
5702374 | Johnson | Dec 1997 | A |
5713485 | Liff et al. | Feb 1998 | A |
5776124 | Wald | Jul 1998 | A |
5785691 | Vetter et al. | Jul 1998 | A |
5797885 | Rubin | Aug 1998 | A |
5807343 | Tucker et al. | Sep 1998 | A |
5829589 | Nguyen et al. | Nov 1998 | A |
D402766 | Smith et al. | Dec 1998 | S |
5842567 | Rowe et al. | Dec 1998 | A |
5876381 | Pond et al. | Mar 1999 | A |
5883806 | Meador et al. | Mar 1999 | A |
5884457 | Ortiz et al. | Mar 1999 | A |
5902269 | Jentzen | May 1999 | A |
5926922 | Stottle | Jul 1999 | A |
5951522 | Rosato et al. | Sep 1999 | A |
5951525 | Thorne et al. | Sep 1999 | A |
5954203 | Marconi | Sep 1999 | A |
5954657 | Rados | Sep 1999 | A |
5957166 | Safabash | Sep 1999 | A |
5957314 | Nishida et al. | Sep 1999 | A |
5963136 | O'Brien | Oct 1999 | A |
5989227 | Vetter et al. | Nov 1999 | A |
5993437 | Raoz | Nov 1999 | A |
6000548 | Tsals | Dec 1999 | A |
D419671 | Jansen | Jan 2000 | S |
6021824 | Larsen et al. | Feb 2000 | A |
6027482 | Imbert | Feb 2000 | A |
6068614 | Kimber et al. | May 2000 | A |
D430293 | Jansen | Aug 2000 | S |
D431864 | Jansen | Oct 2000 | S |
6126640 | Tucker et al. | Oct 2000 | A |
6190364 | Imbert | Feb 2001 | B1 |
6193688 | Balestracci et al. | Feb 2001 | B1 |
6196593 | Petrick et al. | Mar 2001 | B1 |
6196998 | Jansen et al. | Mar 2001 | B1 |
6216885 | Guillaume | Apr 2001 | B1 |
6279746 | Hussaini et al. | Apr 2001 | B1 |
6235376 | Miyazaki et al. | May 2001 | B1 |
6280418 | Reinhard et al. | Aug 2001 | B1 |
6287671 | Bright et al. | Sep 2001 | B1 |
6322543 | Singh et al. | Nov 2001 | B1 |
6338200 | Baxa et al. | Jan 2002 | B1 |
6358241 | Shapeton et al. | Mar 2002 | B1 |
6375640 | Teraoka | Apr 2002 | B1 |
6394983 | Mayoral et al. | May 2002 | B1 |
6439276 | Wood et al. | Aug 2002 | B1 |
6485460 | Eakins et al. | Nov 2002 | B2 |
6488666 | Geist | Dec 2002 | B1 |
6491665 | Vetter et al. | Dec 2002 | B1 |
6500155 | Sasso | Dec 2002 | B2 |
6520935 | Jansen et al. | Feb 2003 | B1 |
6540697 | Chen | Apr 2003 | B2 |
6565529 | Kimber et al. | May 2003 | B1 |
6581792 | Limanjaya | Jun 2003 | B1 |
6585691 | Vitello | Jul 2003 | B1 |
6592251 | Edwards et al. | Jul 2003 | B2 |
6666852 | Niedospial, Jr. | Dec 2003 | B2 |
6682798 | Kiraly | Jan 2004 | B1 |
6726652 | Eakins et al. | Apr 2004 | B2 |
6726672 | Hanly et al. | Apr 2004 | B1 |
6764469 | Broselow | Jul 2004 | B2 |
6796586 | Werth | Sep 2004 | B2 |
6821268 | Balestracci | Nov 2004 | B2 |
D501549 | McAllister et al. | Feb 2005 | S |
6921383 | Vitello | Jul 2005 | B2 |
6935560 | Andreasson et al. | Aug 2005 | B2 |
6942643 | Eakins et al. | Sep 2005 | B2 |
7036661 | Anthony et al. | May 2006 | B2 |
7055273 | Roshkoff | Jun 2006 | B2 |
7100771 | Massengale et al. | Sep 2006 | B2 |
7125397 | Woehr et al. | Oct 2006 | B2 |
7141286 | Kessler et al. | Nov 2006 | B1 |
7175081 | Andreasson et al. | Feb 2007 | B2 |
7182256 | Andreasson et al. | Feb 2007 | B2 |
7232066 | Anderasson et al. | Jun 2007 | B2 |
7240926 | Dalle et al. | Jul 2007 | B2 |
7299981 | Hickle et al. | Nov 2007 | B2 |
7374555 | Heinz et al. | May 2008 | B2 |
7404500 | Marteau et al. | Jul 2008 | B2 |
7410803 | Nollert et al. | Aug 2008 | B2 |
7425208 | Vitello | Sep 2008 | B1 |
7437972 | Yeager | Oct 2008 | B2 |
D581046 | Sudo | Nov 2008 | S |
D581047 | Koshidaka | Nov 2008 | S |
D581049 | Sudo | Nov 2008 | S |
7482166 | Nollert et al. | Jan 2009 | B2 |
D589612 | Sudo | Mar 2009 | S |
7497330 | Anthony et al. | Mar 2009 | B2 |
7503453 | Cronin et al. | Mar 2009 | B2 |
7588563 | Guala | Sep 2009 | B2 |
7594681 | DeCarlo | Sep 2009 | B2 |
7608057 | Woehr et al. | Oct 2009 | B2 |
7611487 | Woehr et al. | Nov 2009 | B2 |
7632244 | Buehler et al. | Dec 2009 | B2 |
D608900 | Giraud et al. | Jan 2010 | S |
7641636 | Moesli et al. | Jan 2010 | B2 |
D612939 | Boone, III et al. | Mar 2010 | S |
7681606 | Khan et al. | Mar 2010 | B2 |
7698180 | Fago et al. | Apr 2010 | B2 |
7735664 | Peters et al. | Jun 2010 | B1 |
7748892 | McCoy | Jul 2010 | B2 |
7762988 | Vitello | Jul 2010 | B1 |
7766919 | Delmotte | Aug 2010 | B2 |
7802313 | Czajka | Sep 2010 | B2 |
7886908 | Farrar et al. | Feb 2011 | B2 |
7918830 | Langan et al. | Apr 2011 | B2 |
7922213 | Werth | Apr 2011 | B2 |
7988004 | Marret et al. | Aug 2011 | B1 |
8034041 | Domkowski et al. | Oct 2011 | B2 |
8079518 | Turner et al. | Dec 2011 | B2 |
8091727 | Domkowwski | Jan 2012 | B2 |
8118788 | Frezza | Feb 2012 | B2 |
8137324 | Bobst | Mar 2012 | B2 |
8140349 | Hanson et al. | Mar 2012 | B2 |
8252247 | Ferlic | Aug 2012 | B2 |
8257286 | Meyer et al. | Sep 2012 | B2 |
8328082 | Bochenko et al. | Dec 2012 | B1 |
8348895 | Vitello | Jan 2013 | B1 |
8353869 | Ranalletta et al. | Jan 2013 | B2 |
8413811 | Arendt | Apr 2013 | B1 |
8443999 | Reinders | May 2013 | B1 |
D684057 | Kwon | Jun 2013 | S |
8512277 | Del Vecchio | Aug 2013 | B2 |
8528757 | Bisio | Sep 2013 | B2 |
8556074 | Turner et al. | Oct 2013 | B2 |
8579116 | Pether et al. | Nov 2013 | B2 |
8591462 | Vitello | Nov 2013 | B1 |
8597255 | Emmott et al. | Dec 2013 | B2 |
8597271 | Langan et al. | Dec 2013 | B2 |
8616413 | Koyama | Dec 2013 | B2 |
D701304 | Lair et al. | Mar 2014 | S |
8672902 | Ruan et al. | Mar 2014 | B2 |
8702674 | Bochenko | Apr 2014 | B2 |
8777910 | Bauss et al. | Jul 2014 | B2 |
8777930 | Swisher et al. | Jul 2014 | B2 |
8852561 | Wagner et al. | Oct 2014 | B2 |
8864021 | Vitello | Oct 2014 | B1 |
8864707 | Vitello | Oct 2014 | B1 |
8864708 | Vitello | Oct 2014 | B1 |
8911424 | Weadock et al. | Dec 2014 | B2 |
8945082 | Geiger et al. | Feb 2015 | B2 |
9016473 | Tamarindo | Apr 2015 | B2 |
9082157 | Gibson | Jul 2015 | B2 |
9101534 | Bochenko | Aug 2015 | B2 |
D738495 | Strong et al. | Sep 2015 | S |
9125976 | Uber, III et al. | Sep 2015 | B2 |
D743019 | Schultz | Nov 2015 | S |
9199042 | Farrar et al. | Dec 2015 | B2 |
9199749 | Vitello et al. | Dec 2015 | B1 |
9220486 | Schweiss et al. | Dec 2015 | B2 |
9220577 | Jessop et al. | Dec 2015 | B2 |
D750228 | Strong et al. | Feb 2016 | S |
9272099 | Limaye et al. | Mar 2016 | B2 |
9311592 | Vitello et al. | Apr 2016 | B1 |
D756777 | Berge et al. | May 2016 | S |
9336669 | Bowden et al. | May 2016 | B2 |
D759486 | Ingram et al. | Jun 2016 | S |
D760384 | Niunoya et al. | Jun 2016 | S |
D760902 | Persson | Jul 2016 | S |
9402967 | Vitello | Aug 2016 | B1 |
9427715 | Palazzolo et al. | Aug 2016 | B2 |
9433768 | Tekeste et al. | Sep 2016 | B2 |
9463310 | Vitello | Oct 2016 | B1 |
D773043 | Ingram et al. | Nov 2016 | S |
D777903 | Schultz | Jan 2017 | S |
9662456 | Woehr | May 2017 | B2 |
D789529 | Davis et al. | Jun 2017 | S |
9687249 | Hanlon et al. | Jun 2017 | B2 |
9744304 | Swift et al. | Aug 2017 | B2 |
D797928 | Davis et al. | Sep 2017 | S |
D797929 | Davis et al. | Sep 2017 | S |
9764098 | Hund et al. | Sep 2017 | B2 |
9821152 | Vitello et al. | Nov 2017 | B1 |
D806241 | Swinney et al. | Dec 2017 | S |
D807503 | Davis et al. | Jan 2018 | S |
9855191 | Vitello et al. | Jan 2018 | B1 |
D815945 | Fischer | Apr 2018 | S |
9987438 | Stillson | Jun 2018 | B2 |
D825746 | Davis et al. | Aug 2018 | S |
10039913 | Yeh et al. | Aug 2018 | B2 |
D831201 | Holtz et al. | Oct 2018 | S |
D834187 | Ryan | Nov 2018 | S |
10124122 | Zenker | Nov 2018 | B2 |
10166343 | Hunt et al. | Jan 2019 | B1 |
10166347 | Vitello | Jan 2019 | B1 |
10183129 | Vitello | Jan 2019 | B1 |
10207099 | Vitello | Feb 2019 | B1 |
D842464 | Davis et al. | Mar 2019 | S |
D847373 | Hurwit et al. | Apr 2019 | S |
10300263 | Hunt | May 2019 | B1 |
10307548 | Hunt et al. | Jun 2019 | B1 |
10315024 | Vitello et al. | Jun 2019 | B1 |
10315808 | Taylor et al. | Jun 2019 | B2 |
10376655 | Pupke et al. | Aug 2019 | B2 |
D859125 | Weagle et al. | Sep 2019 | S |
10478262 | Niese et al. | Nov 2019 | B2 |
10758684 | Vitello et al. | Sep 2020 | B1 |
10773067 | Davis et al. | Sep 2020 | B2 |
10888672 | Vitello | Jan 2021 | B1 |
10898659 | Vitello et al. | Jan 2021 | B1 |
10912898 | Vitello et al. | Feb 2021 | B1 |
10933202 | Banik | Mar 2021 | B1 |
10953162 | Hunt et al. | Mar 2021 | B1 |
11040149 | Banik | Jun 2021 | B1 |
11040154 | Vitello et al. | Jun 2021 | B1 |
11097071 | Hunt et al. | Aug 2021 | B1 |
11278681 | Banik et al. | Mar 2022 | B1 |
D948713 | Banik | Apr 2022 | S |
11357588 | Vitello et al. | Jun 2022 | B1 |
11413406 | Vitello et al. | Aug 2022 | B1 |
11426328 | Ollmann et al. | Aug 2022 | B1 |
11471610 | Banik et al. | Oct 2022 | B1 |
11523970 | Vitello et al. | Dec 2022 | B1 |
11541180 | Vitello et al. | Jan 2023 | B1 |
11690994 | Banik et al. | Jul 2023 | B1 |
11697527 | Hendren et al. | Jul 2023 | B1 |
11779520 | Vitello | Oct 2023 | B1 |
11793987 | Vitello et al. | Oct 2023 | B1 |
11857751 | Vitello | Jan 2024 | B1 |
11872187 | Vitello et al. | Jan 2024 | B1 |
11904149 | Vitello et al. | Feb 2024 | B1 |
11911339 | Lehel et al. | Feb 2024 | B1 |
20010056258 | Evans | Dec 2001 | A1 |
20020023409 | Py | Feb 2002 | A1 |
20020046962 | Vallans et al. | Apr 2002 | A1 |
20020079281 | Hierzer et al. | Jun 2002 | A1 |
20020097396 | Schafer | Jul 2002 | A1 |
20020099334 | Hanson et al. | Jul 2002 | A1 |
20020101656 | Blumenthal et al. | Aug 2002 | A1 |
20020104770 | Shapeton et al. | Aug 2002 | A1 |
20020133119 | Eakins et al. | Sep 2002 | A1 |
20030055685 | Cobb et al. | Mar 2003 | A1 |
20030146617 | Franko, Sr. | Aug 2003 | A1 |
20030183547 | Heyman | Oct 2003 | A1 |
20030187403 | Balestracci | Oct 2003 | A1 |
20040008123 | Carrender et al. | Jan 2004 | A1 |
20040064095 | Vitello | Apr 2004 | A1 |
20040116858 | Heinz et al. | Jun 2004 | A1 |
20040173563 | Kim et al. | Sep 2004 | A1 |
20040186437 | Frenette et al. | Sep 2004 | A1 |
20040225258 | Balestracci | Nov 2004 | A1 |
20050146081 | MacLean et al. | Jul 2005 | A1 |
20050148941 | Farrar et al. | Jul 2005 | A1 |
20050209555 | Middleton et al. | Sep 2005 | A1 |
20060084925 | Ramsahoye | Apr 2006 | A1 |
20060089601 | Dionigi | Apr 2006 | A1 |
20060169611 | Prindle | Aug 2006 | A1 |
20060173415 | Cummins | Aug 2006 | A1 |
20060189933 | Alheidt et al. | Aug 2006 | A1 |
20070060898 | Shaughnessy et al. | Mar 2007 | A1 |
20070106234 | Klein | May 2007 | A1 |
20070142786 | Lampropoulos et al. | Jun 2007 | A1 |
20070191690 | Hasse et al. | Aug 2007 | A1 |
20070219503 | Loop et al. | Sep 2007 | A1 |
20070257111 | Ortenzi | Nov 2007 | A1 |
20080068178 | Meyer | Mar 2008 | A1 |
20080097310 | Buehler et al. | Apr 2008 | A1 |
20080106388 | Knight | May 2008 | A1 |
20080140020 | Shirley | Jun 2008 | A1 |
20080243088 | Evans | Oct 2008 | A1 |
20080303267 | Schnell et al. | Dec 2008 | A1 |
20080306443 | Neer | Dec 2008 | A1 |
20090084804 | Caspary et al. | Apr 2009 | A1 |
20090099552 | Levy et al. | Apr 2009 | A1 |
20090149815 | Kiel et al. | Jun 2009 | A1 |
20090166311 | Claessens | Jul 2009 | A1 |
20090326481 | Swisher et al. | Dec 2009 | A1 |
20100050351 | Colantonio et al. | Mar 2010 | A1 |
20100051491 | Lampropoulos et al. | Mar 2010 | A1 |
20100084403 | Popish et al. | Apr 2010 | A1 |
20100126894 | Koukol et al. | May 2010 | A1 |
20100179822 | Reppas | Jul 2010 | A1 |
20100211016 | Palmer-Felgate | Aug 2010 | A1 |
20100228226 | Nielsen | Sep 2010 | A1 |
20100252564 | Martinez et al. | Oct 2010 | A1 |
20100283238 | Deighan et al. | Nov 2010 | A1 |
20110044850 | Solomon et al. | Feb 2011 | A1 |
20110046550 | Schiller et al. | Feb 2011 | A1 |
20110046603 | Felsovalyi et al. | Feb 2011 | A1 |
20120064515 | Knapp et al. | Mar 2012 | A2 |
20120096957 | Ochman | Apr 2012 | A1 |
20120110950 | Schraudolph | May 2012 | A1 |
20130018356 | Prince et al. | Jan 2013 | A1 |
20130056130 | Alpert et al. | Mar 2013 | A1 |
20130088354 | Thomas | Apr 2013 | A1 |
20130237949 | Miller | Sep 2013 | A1 |
20130269592 | Heacock et al. | Oct 2013 | A1 |
20140000781 | Franko, Jr. | Jan 2014 | A1 |
20140034536 | Reinhardt et al. | Feb 2014 | A1 |
20140069202 | Fisk | Mar 2014 | A1 |
20140069829 | Evans | Mar 2014 | A1 |
20140076840 | Graux et al. | Mar 2014 | A1 |
20140135738 | Panian | May 2014 | A1 |
20140155868 | Nelson et al. | Jun 2014 | A1 |
20140163465 | Bartlett, II et al. | Jun 2014 | A1 |
20140257843 | Adler et al. | Sep 2014 | A1 |
20140326727 | Jouin et al. | Nov 2014 | A1 |
20140353196 | Key | Dec 2014 | A1 |
20150013811 | Carrel et al. | Jan 2015 | A1 |
20150048045 | Miceli et al. | Feb 2015 | A1 |
20150112296 | Ishiwata et al. | Apr 2015 | A1 |
20150136632 | Moir et al. | May 2015 | A1 |
20150182686 | Okihara | Jul 2015 | A1 |
20150191633 | De Boer et al. | Jul 2015 | A1 |
20150246185 | Heinz | Sep 2015 | A1 |
20150302232 | Strassburger et al. | Oct 2015 | A1 |
20150305982 | Bochenko | Oct 2015 | A1 |
20150310771 | Atkinson et al. | Oct 2015 | A1 |
20160067144 | Chang | Mar 2016 | A1 |
20160067422 | Davis et al. | Mar 2016 | A1 |
20160090456 | Ishimaru et al. | Mar 2016 | A1 |
20160136352 | Smith et al. | May 2016 | A1 |
20160144119 | Limaye et al. | May 2016 | A1 |
20160158110 | Swisher et al. | Jun 2016 | A1 |
20160158449 | Limaye et al. | Jun 2016 | A1 |
20160176550 | Viitello et al. | Jun 2016 | A1 |
20160194121 | Ogawa et al. | Jul 2016 | A1 |
20160250420 | Maritan et al. | Sep 2016 | A1 |
20160279032 | Davis | Sep 2016 | A1 |
20160328586 | Bowden et al. | Nov 2016 | A1 |
20160361235 | Swisher | Dec 2016 | A1 |
20160367439 | Davis et al. | Dec 2016 | A1 |
20170007771 | Duinat et al. | Jan 2017 | A1 |
20170014310 | Hyun et al. | Jan 2017 | A1 |
20170124289 | Hasan et al. | May 2017 | A1 |
20170173321 | Davis et al. | Jun 2017 | A1 |
20170203086 | Davis | Jul 2017 | A1 |
20170225843 | Glaser et al. | Aug 2017 | A1 |
20170239141 | Davis et al. | Aug 2017 | A1 |
20170297781 | Kawamura | Oct 2017 | A1 |
20170319438 | Davis et al. | Nov 2017 | A1 |
20170354792 | Ward | Dec 2017 | A1 |
20180001540 | Byun | Jan 2018 | A1 |
20180014998 | Yuki et al. | Jan 2018 | A1 |
20180064604 | Drmanovic | Mar 2018 | A1 |
20180078684 | Peng et al. | Mar 2018 | A1 |
20180089593 | Patel et al. | Mar 2018 | A1 |
20180098915 | Rajagopal et al. | Apr 2018 | A1 |
20180147115 | Nishioka et al. | May 2018 | A1 |
20180312305 | Rognard | Nov 2018 | A1 |
20190308006 | Erekovcanski et al. | Oct 2019 | A1 |
20190388626 | Okihara | Dec 2019 | A1 |
20220008645 | Ukai et al. | Jan 2022 | A1 |
Number | Date | Country |
---|---|---|
202008018507 | Feb 2015 | DE |
0148116 | Jul 1985 | EP |
269920 | Jun 1988 | EP |
486367 | Jun 1938 | GB |
08002544 | Jan 1996 | JP |
101159987 | Jun 2012 | KR |
WO2008000279 | Jan 2008 | WO |
WO2017086607 | May 2015 | WO |
Entry |
---|
Arai Tsugio, Pilfering Proof Cap, Jan. 1, 1996. |
Number | Date | Country | |
---|---|---|---|
63125156 | Dec 2020 | US |